Heart 1999;82:448-454 ( October )

Serum total homocysteine and coronary heart disease: prospective study in middle aged men

P H Whincup^a, H Refsum^b, I J Perry^c, R Morris^a, M Walker^a, L Lennon^a, A Thomson^a, P M Ueland^b, S B J Ebrahim^a

^a Cardiovascular Research Unit, Department of Primary Care and Population Sciences, Royal Free Hospital School of Medicine, London NW3 2PF, UK, ^b Department of Pharmacology, University of Bergen, Bergen, Norway, ^c Department of Epidemiology and Public Health, University College, Cork, Republic of Ireland

Correspondence to: Dr Whincup. email: peterw{at}rfhsm.ac.uk

Accepted for publication 17 May 1999

OBJECTIVESTo examine the prospective relation between total homocysteine and major coronary heart disease events.
DESIGNA nested case-control study carried out within the British regional heart study, a prospective investigation of cardiovascular disease in men aged 40-59 years at entry. Serum total homocysteine concentrations were analysed retrospectively and blindly in baseline samples from 386 cases who had a myocardial infarct during 12.8 years of follow up and from 454 controls, frequency matched by age and town.
RESULTSGeometric mean serum total homocysteine was slightly higher in cases (14.2 µmol/l) than in controls (13.5 µmol/l), a proportional difference of 5.5% (95% confidence interval (CI) 0.02% to 10.8%, p = 0.06). Age adjusted risk of myocardial infarction increased weakly with log total homocysteine concentration; a 1 SD increase in log total homocysteine (equivalent to a 47% increase in total homo cysteine) was associated with an increase in odds of myocardial infarction of 1.15 (95% CI 1.00 to 1.32; p = 0.05). The relation was particularly marked in the top fifth of the total homocysteine distribution (values >16.5 µmol/l), which had an odds ratio of 1.77 (95% CI 1.28 to 2.42) compared with lower levels. Adjustment for other risk factors had little effect on these findings. Total homocysteine concentrations more than 16.5 µmol/l accounted for 13% of the attributable risk of myocardial infarction in this study population. Serum total homocysteine among control subjects varied between towns and was correlated with town standardised mortality ratios for coronary heart disease (r = 0.43, p = 0.08).
CONCLUSIONSSerum total homocysteine is prospectively related to increased coronary risk and may also be related to geographical variation in coronary risk within Britain. These results strengthen the case for trials of total homocysteine reduction with folate.


Keywords: coronary heart disease; homocysteine; epidemiology

---

© 1999 by Heart
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Humphrey, L. L., Fu, R., Rogers, K., Freeman, M., Helfand, M. (2008). Homocysteine Level and Coronary Heart Disease Incidence: A Systematic Review and Meta-analysis. Mayo Clin Proc. 83: 1203-1212 [Abstract] [Full Text]  
• Shimano, M., Inden, Y., Tsuji, Y., Kamiya, H., Uchikawa, T., Shibata, R., Murohara, T. (2008). Circulating homocysteine levels in patients with radiofrequency catheter ablation for atrial fibrillation. Europace 10: 961-966 [Abstract] [Full Text]  
• Ebbesen, L. S., Ingerslev, J. (2005). Folate Deficiency-Induced Hyperhomocysteinemia Attenuates, and Folic Acid Supplementation Restores, the Functional Activities of Rat Coagulation Factors XII, X, and II. J. Nutr. 135: 1836-1840 [Abstract] [Full Text]  
• Pac, F. A., Ozerol, E., Ozerol, I. H., Temel, I., Ege, E., Yologlu, S., Sezgin, N., Sahin, K., Emmiler, M., Pac, M., Aslan, H. (2005). Homocysteine, Lipid Profile, Nitric Oxide, Vitamin B12, and Folate Values in Patients with Premature Coronary Artery Disease and Their Children. ANGIOLOGY 56: 253-257 [Abstract]  
• Vrentzos, G., Papadakis, J. A., Malliaraki, N., Zacharis, E. A., Katsogridakis, K., Margioris, A. N., Vardas, P. E., Ganotakis, E. S. (2004). Association of Serum Total Homocysteine with the Extent of Ischemic Heart Disease in a Mediterranean Cohort. ANGIOLOGY 55: 517-524 [Abstract]  
• Emberson, J. R, Whincup, P. H, Morris, R. W, Walker, M. (2004). Social class differences in coronary heart disease in middle-aged British men: implications for prevention. Int J Epidemiol 33: 289-296 [Abstract] [Full Text]  
• Nadar, S., Lip, G. Y.H. (2003). Homocysteine and the Risk of Stroke and Thromboembolism in Atrial Fibrillation: An Uncertain Role. Stroke 34 : e143-e143 [Full Text]  
• Ebbesen, L. S., Christiansen, K., Ingerslev, J. (2003). Hyperhomocysteinemia Due to Folate Deficiency Is Thrombogenic in Rats. J. Nutr. 133: 2250-2255 [Abstract] [Full Text]  
• Vasan, R. S., Beiser, A., D'Agostino, R. B., Levy, D., Selhub, J., Jacques, P. F., Rosenberg, I. H., Wilson, P. W. F. (2003). Plasma Homocysteine and Risk for Congestive Heart Failure in Adults Without Prior Myocardial Infarction. JAMA 289: 1251-1257 [Abstract] [Full Text]  
• Chandalia, M., Abate, N., Cabo-Chan, A. V. Jr., Devaraj, S., Jialal, I., Grundy, S. M. (2003). Hyperhomocysteinemia in Asian Indians Living in the United States. J. Clin. Endocrinol. Metab. 88: 1089-1095 [Abstract] [Full Text]  
• (2002). References. Circulation 106: 3373-3421 [Full Text]  
• Lim, U., Cassano, P. A. (2002). Homocysteine and Blood Pressure in the Third National Health and Nutrition Examination Survey, 1988-1994. Am J Epidemiol 156: 1105-1113 [Abstract] [Full Text]  
• De Bree, A., Verschuren, W. M. M., Kromhout, D., Kluijtmans, L. A. J., Blom, H. J. (2002). Homocysteine Determinants and the Evidence to What Extent Homocysteine Determines the Risk of Coronary Heart Disease. Pharmacol. Rev. 54: 599-618 [Abstract] [Full Text]  
• Beaglehole, R., Magnus, P. (2002). The search for new risk factors for coronary heart disease: occupational therapy for epidemiologists?. Int J Epidemiol 31: 1117-1122 [Abstract] [Full Text]  
• De Bree, A., Verschuren, W. M., Kromhout, D., Mennen, L. I, Blom, H. J, Ford, E. S, Smith, S J., Stroup, D. F, Steinberg, K. K, Mueller, P. W, Thacker, S. B (2002). Homocysteine and coronary heart disease: the importance of a distinction between low and high risk subjects. Int J Epidemiol 31: 1268-1272 [Full Text]  
• Jensen-Urstad, K, Svenungsson, E, de Faire, U, Silveira, A, Witztum, J L, Hamsten, A, Frostegard, J (2002). Cardiac valvular abnormalities are frequent in systemic lupus erythematosus patients with manifest arterial disease. Lupus 11: 744-752 [Abstract]  
• Homocysteine Studies Collaboration, (2002). Homocysteine and Risk of Ischemic Heart Disease and Stroke: A Meta-analysis. JAMA 288: 2015-2022 [Abstract] [Full Text]  
• Weiss, N., Keller, C., Hoffmann, U., Loscalzo, J. (2002). Endothelial dysfunction and atherothrombosis in mild hyperhomocysteinemia. Vasc Med 7: 227-239 [Abstract]  
• Dimitrova, K. R, DeGroot, K., Myers, A. K, Kim, Y. D (2002). Estrogen and homocysteine. Cardiovasc Res 53: 577-588 [Abstract] [Full Text]  
• Ford, E. S, Smith, S J., Stroup, D. F, Steinberg, K. K, Mueller, P. W, Thacker, S. B (2002). Homocyst(e)ine and cardiovascular disease: a systematic review of the evidence with special emphasis on case-control studies and nested case-control studies. Int J Epidemiol 31: 59-70 [Abstract] [Full Text]  
• Knekt, P., Reunanen, A., Alfthan, G., Heliovaara, M., Rissanen, H., Marniemi, J., Aromaa, A. (2001). Hyperhomocystinemia: A Risk Factor or a Consequence of Coronary Heart Disease?. Arch Intern Med 161: 1589-1594 [Abstract] [Full Text]  
• Fallon, U B, Elwood, P, Ben-Shlomo, Y, Ubbink, J B, Greenwood, R, Smith, G D. (2001). Homocysteine and ischaemic stroke in men: the Caerphilly study. J. Epidemiol. Community Health 55: 91-96 [Abstract] [Full Text]  
• Fallon, U B, Ben-Shlomo, Y, Elwood, P, Ubbink, J B, Smith, G D. (2001). Homocysteine and coronary heart disease in the Caerphilly cohort: a 10 year follow up. Heart 85: 153-158 [Abstract] [Full Text]  
• Ueland, P. M, Refsum, H., Beresford, S. A., Vollset, S. E. (2000). The controversy over homocysteine and cardiovascular risk. Am. J. Clin. Nutr. 72: 324-332 [Abstract] [Full Text]